Most nasal lymphomas in these populations are of NK-cell lineage ... The role of autologous and allogeneic hematopoietic stem-cell transplantation should be established by controlled trials.

Troculeucel is an autologous NK cell therapy, which means it is derived from a patient's own immune cells and expanded ...

In addition, autologous cell transplantation is not ... development efforts have focused on safe and effective allogeneic NK cell transfusion procedures, in which a patient receives cells from ...

Troculeucel is a novel cell-based, patient specific, ex vivo expanded autologous NK cell immunotherapeutic drug candidate. NKGen is developing troculeucel for the treatment of neurodegenerative ...

About Troculeucel Troculeucel is a novel cell-based, patient specific, ex vivo expanded autologous NK cell immunotherapeutic drug candidate. NKGen is developing troculeucel for the treatment of ...

With a bone marrow transplant, the stem cells are taken from the bone marrow. With a stem cell transplant, the stem cells are taken from either the bone marrow or the bloodstream. There are 2 main ...

Most nasal lymphomas in these populations are of NK-cell lineage ... The role of autologous and allogeneic hematopoietic stem-cell transplantation should be established by controlled trials.

March 25, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) ("NKGen” or the "Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative ...

Troculeucel is a novel cell-based, patient specific, ex vivo expanded autologous NK cell immunotherapeutic drug candidate. NKGen is developing troculeucel for the treatment of neurodegenerative ...